The US Food and Drug Administration (FDA) has cleared Prodeon Medical's implantable technology for treating lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Butterfly Medical has raised $21m in Series C funding for the development and potential commercialisation of its minimally invasive device for benign prostatic hyperplasia (BPH). This latest funding ...
NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the World Congress of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results